Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 872 entries
Sorted by: Best Match Show Resources per page
Erratum.

British journal of haematology

[No authors listed]
PMID: 26171562
Br J Haematol. 2015 Aug;170(3):440. doi: 10.1111/bjh.13587.

No abstract available.

Cite
Erratum. Br J Haematol. 2015;170(3):440doi: 10.1111/bjh.13587.
(2015). Erratum. British journal of haematology, 170(3), 440. https://doi.org/10.1111/bjh.13587
"Erratum." British journal of haematology vol. 170,3 (2015): 440. doi: https://doi.org/10.1111/bjh.13587
Erratum. Br J Haematol. 2015 Aug;170(3):440. doi: 10.1111/bjh.13587. PMID: 26171562.
Copy Download .nbib Format: NLM
Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options.

British journal of haematology

Brisse E, Matthys P, Wouters CH.
PMID: 27292929
Br J Haematol. 2016 Jul;174(2):175-87. doi: 10.1111/bjh.14144. Epub 2016 Jun 12.

The cytokine storm syndrome 'haemophagocytic lymphohistiocytosis' (HLH) is an under-recognized hyperinflammatory disorder, causing high morbidity and mortality risk in children and adults. It can be subdivided into a primary, genetic form and a secondary, acquired form that complicates diverse...

Cite
Brisse E, Matthys P, Wouters CH. Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options. Br J Haematol. 2016;174(2):175-87doi: 10.1111/bjh.14144.
Brisse, E., Matthys, P., & Wouters, C. H. (2016). Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options. British journal of haematology, 174(2), 175-87. https://doi.org/10.1111/bjh.14144
Brisse, Ellen, et al. "Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options." British journal of haematology vol. 174,2 (2016): 175-87. doi: https://doi.org/10.1111/bjh.14144
Brisse E, Matthys P, Wouters CH. Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options. Br J Haematol. 2016 Jul;174(2):175-87. doi: 10.1111/bjh.14144. Epub 2016 Jun 12. PMID: 27292929.
Copy Download .nbib Format: NLM
Corrigendum.

British journal of haematology

[No authors listed]
PMID: 26464263
Br J Haematol. 2015 Nov;171(3):440. doi: 10.1111/bjh.13774.

No abstract available.

Cite
Corrigendum. Br J Haematol. 2015;171(3):440doi: 10.1111/bjh.13774.
(2015). Corrigendum. British journal of haematology, 171(3), 440. https://doi.org/10.1111/bjh.13774
"Corrigendum." British journal of haematology vol. 171,3 (2015): 440. doi: https://doi.org/10.1111/bjh.13774
Corrigendum. Br J Haematol. 2015 Nov;171(3):440. doi: 10.1111/bjh.13774. PMID: 26464263.
Copy Download .nbib Format: NLM
CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q).

British journal of haematology

Bello E, Pellagatti A, Shaw J, Mecucci C, Kušec R, Killick S, Giagounidis A, Raynaud S, Calasanz MJ, Fenaux P, Boultwood J.
PMID: 26085061
Br J Haematol. 2015 Oct;171(2):210-214. doi: 10.1111/bjh.13563. Epub 2015 Jun 18.

Mutations of CSNK1A1, a gene mapping to the commonly deleted region of the 5q- syndrome, have been recently described in patients with del(5q) myelodysplastic syndromes (MDS). Haploinsufficiency of Csnk1a1 in mice has been shown to result in β-catenin activation...

Cite
Bello E, Pellagatti A, Shaw J, et al. CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q). Br J Haematol. 2015;171(2):210-214doi: 10.1111/bjh.13563.
Bello, E., Pellagatti, A., Shaw, J., Mecucci, C., Kušec, R., Killick, S., Giagounidis, A., Raynaud, S., Calasanz, M. J., Fenaux, P., & Boultwood, J. (2015). CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q). British journal of haematology, 171(2), 210-214. https://doi.org/10.1111/bjh.13563
Bello, Erica, et al. "CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q)." British journal of haematology vol. 171,2 (2015): 210-214. doi: https://doi.org/10.1111/bjh.13563
Bello E, Pellagatti A, Shaw J, Mecucci C, Kušec R, Killick S, Giagounidis A, Raynaud S, Calasanz MJ, Fenaux P, Boultwood J. CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q). Br J Haematol. 2015 Oct;171(2):210-214. doi: 10.1111/bjh.13563. Epub 2015 Jun 18. PMID: 26085061; PMCID: PMC4744770.
Copy Download .nbib Format: NLM
Corrigendum.

British journal of haematology

[No authors listed]
PMID: 26767470
Br J Haematol. 2016 Jan;172(1):148. doi: 10.1111/bjh.13854.

No abstract available.

Cite
Corrigendum. Br J Haematol. 2016;172(1):148doi: 10.1111/bjh.13854.
(2016). Corrigendum. British journal of haematology, 172(1), 148. https://doi.org/10.1111/bjh.13854
"Corrigendum." British journal of haematology vol. 172,1 (2016): 148. doi: https://doi.org/10.1111/bjh.13854
Corrigendum. Br J Haematol. 2016 Jan;172(1):148. doi: 10.1111/bjh.13854. PMID: 26767470.
Copy Download .nbib Format: NLM
rHuEpo TREATMENT IN LOW-RISK MYELODYSPLASTIC SYNDROMES: A REPLY .

British journal of haematology

Grossi A.
PMID: 10460629
Br J Haematol. 1999 Aug;106(2):574. doi: 10.1046/j.1365-2141.1999.1622a.x.

No abstract available.

Cite
Grossi A. rHuEpo TREATMENT IN LOW-RISK MYELODYSPLASTIC SYNDROMES: A REPLY . Br J Haematol. 1999;106(2):574doi: 10.1046/j.1365-2141.1999.1622a.x.
Grossi, A. (1999). rHuEpo TREATMENT IN LOW-RISK MYELODYSPLASTIC SYNDROMES: A REPLY . British journal of haematology, 106(2), 574. https://doi.org/10.1046/j.1365-2141.1999.1622a.x
Grossi. "rHuEpo TREATMENT IN LOW-RISK MYELODYSPLASTIC SYNDROMES: A REPLY ." British journal of haematology vol. 106,2 (1999): 574. doi: https://doi.org/10.1046/j.1365-2141.1999.1622a.x
Grossi A. rHuEpo TREATMENT IN LOW-RISK MYELODYSPLASTIC SYNDROMES: A REPLY . Br J Haematol. 1999 Aug;106(2):574. doi: 10.1046/j.1365-2141.1999.1622a.x. PMID: 10460629.
Copy Download .nbib Format: NLM
Th1/Th2 LYMPHOCYTE SUBSETS IN PURE RED CELL APLASIA .

British journal of haematology

Tsuda H.
PMID: 10233443
Br J Haematol. 1999 May;105(2):570. doi: 10.1111/j.1365-2141.1999.1420b.x.

No abstract available.

Cite
Tsuda H. Th1/Th2 LYMPHOCYTE SUBSETS IN PURE RED CELL APLASIA . Br J Haematol. 1999;105(2):570doi: 10.1111/j.1365-2141.1999.1420b.x.
Tsuda, H. (1999). Th1/Th2 LYMPHOCYTE SUBSETS IN PURE RED CELL APLASIA . British journal of haematology, 105(2), 570. https://doi.org/10.1111/j.1365-2141.1999.1420b.x
Tsuda. "Th1/Th2 LYMPHOCYTE SUBSETS IN PURE RED CELL APLASIA ." British journal of haematology vol. 105,2 (1999): 570. doi: https://doi.org/10.1111/j.1365-2141.1999.1420b.x
Tsuda H. Th1/Th2 LYMPHOCYTE SUBSETS IN PURE RED CELL APLASIA . Br J Haematol. 1999 May;105(2):570. doi: 10.1111/j.1365-2141.1999.1420b.x. PMID: 10233443.
Copy Download .nbib Format: NLM
Reply to telfer et al.

British journal of haematology

Galvani DW.
PMID: 11054099
Br J Haematol. 2000 Sep;110(4):1002-14. doi: 10.1046/j.1365-2141.2000.02270-3.x.

No abstract available.

Cite
Galvani DW. Reply to telfer et al. Br J Haematol. 2000;110(4):1002-14doi: 10.1046/j.1365-2141.2000.02270-3.x.
Galvani, D. W. (2000). Reply to telfer et al. British journal of haematology, 110(4), 1002-14. https://doi.org/10.1046/j.1365-2141.2000.02270-3.x
Galvani. "Reply to telfer et al." British journal of haematology vol. 110,4 (2000): 1002-14. doi: https://doi.org/10.1046/j.1365-2141.2000.02270-3.x
Galvani DW. Reply to telfer et al. Br J Haematol. 2000 Sep;110(4):1002-14. doi: 10.1046/j.1365-2141.2000.02270-3.x. PMID: 11054099.
Copy Download .nbib Format: NLM
Infectious purpura fulminans: caution needed in the use of protein c .

British journal of haematology

Smith OP, White B.
PMID: 10444324
Br J Haematol. 1999 Jul;106(1):253-4. doi: 10.1046/j.1365-2141.1999.1561b.x.

No abstract available.

Cite
Smith OP, White B. Infectious purpura fulminans: caution needed in the use of protein c . Br J Haematol. 1999;106(1):253-4doi: 10.1046/j.1365-2141.1999.1561b.x.
Smith, O. P., & White, B. (1999). Infectious purpura fulminans: caution needed in the use of protein c . British journal of haematology, 106(1), 253-4. https://doi.org/10.1046/j.1365-2141.1999.1561b.x
Smith, and White. "Infectious purpura fulminans: caution needed in the use of protein c ." British journal of haematology vol. 106,1 (1999): 253-4. doi: https://doi.org/10.1046/j.1365-2141.1999.1561b.x
Smith OP, White B. Infectious purpura fulminans: caution needed in the use of protein c . Br J Haematol. 1999 Jul;106(1):253-4. doi: 10.1046/j.1365-2141.1999.1561b.x. PMID: 10444324.
Copy Download .nbib Format: NLM
Reply to drach et al.

British journal of haematology

Avet-Loiseau H.
PMID: 10792303
Br J Haematol. 2000 Mar;108(4):887. doi: 10.1046/j.1365-2141.2000.01909.x.

No abstract available.

Cite
Avet-Loiseau H. Reply to drach et al. Br J Haematol. 2000;108(4):887doi: 10.1046/j.1365-2141.2000.01909.x.
Avet-Loiseau, H. (2000). Reply to drach et al. British journal of haematology, 108(4), 887. https://doi.org/10.1046/j.1365-2141.2000.01909.x
Avet-Loiseau. "Reply to drach et al." British journal of haematology vol. 108,4 (2000): 887. doi: https://doi.org/10.1046/j.1365-2141.2000.01909.x
Avet-Loiseau H. Reply to drach et al. Br J Haematol. 2000 Mar;108(4):887. doi: 10.1046/j.1365-2141.2000.01909.x. PMID: 10792303.
Copy Download .nbib Format: NLM
Fanconi anaemia - response to Manoharan.

British journal of haematology

Hanenberg H, Huck K, Gudowius S, Göbel U, Kobbe G, Haas R, Kalb R, Neveling K, Schindler D.
PMID: 16925571
Br J Haematol. 2006 Oct;135(1):139-40. doi: 10.1111/j.1365-2141.2006.06263.x. Epub 2006 Aug 22.

No abstract available.

Cite
Hanenberg H, Huck K, Gudowius S, et al. Fanconi anaemia - response to Manoharan. Br J Haematol. 2006;135(1):139-40doi: 10.1111/j.1365-2141.2006.06263.x.
Hanenberg, H., Huck, K., Gudowius, S., Göbel, U., Kobbe, G., Haas, R., Kalb, R., Neveling, K., & Schindler, D. (2006). Fanconi anaemia - response to Manoharan. British journal of haematology, 135(1), 139-40. https://doi.org/10.1111/j.1365-2141.2006.06263.x
Hanenberg, Helmut, et al. "Fanconi anaemia - response to Manoharan." British journal of haematology vol. 135,1 (2006): 139-40. doi: https://doi.org/10.1111/j.1365-2141.2006.06263.x
Hanenberg H, Huck K, Gudowius S, Göbel U, Kobbe G, Haas R, Kalb R, Neveling K, Schindler D. Fanconi anaemia - response to Manoharan. Br J Haematol. 2006 Oct;135(1):139-40. doi: 10.1111/j.1365-2141.2006.06263.x. Epub 2006 Aug 22. PMID: 16925571.
Copy Download .nbib Format: NLM
Successful treatment of chronic disseminated candidiasis with high-dose fluconazole in a child with acute myelo-monocytic leukemia.

International journal of antimicrobial agents

Higashigawa M, Azuma E, Shimono Y, Taniguchi K, Sakurai M.
PMID: 18611536
Int J Antimicrob Agents. 1993;2(4):231-6. doi: 10.1016/0924-8579(93)90056-b.

A 6-year-old boy with acute myelo-monocytic leukemia [French-American-British classification, M4 (Bennett et al., Br J Haematol 1976; 33: 451-458)] developed chronic disseminated candidiasis (CDC) in a phase of remission induction chemotherapy. The diagnosis was made based on the histological...

Cite
Higashigawa M, Azuma E, Shimono Y, et al. Successful treatment of chronic disseminated candidiasis with high-dose fluconazole in a child with acute myelo-monocytic leukemia. Int J Antimicrob Agents. 1993;2(4):231-6doi: 10.1016/0924-8579(93)90056-b.
Higashigawa, M., Azuma, E., Shimono, Y., Taniguchi, K., & Sakurai, M. (1993). Successful treatment of chronic disseminated candidiasis with high-dose fluconazole in a child with acute myelo-monocytic leukemia. International journal of antimicrobial agents, 2(4), 231-6. https://doi.org/10.1016/0924-8579(93)90056-b
Higashigawa, M, et al. "Successful treatment of chronic disseminated candidiasis with high-dose fluconazole in a child with acute myelo-monocytic leukemia." International journal of antimicrobial agents vol. 2,4 (1993): 231-6. doi: https://doi.org/10.1016/0924-8579(93)90056-b
Higashigawa M, Azuma E, Shimono Y, Taniguchi K, Sakurai M. Successful treatment of chronic disseminated candidiasis with high-dose fluconazole in a child with acute myelo-monocytic leukemia. Int J Antimicrob Agents. 1993;2(4):231-6. doi: 10.1016/0924-8579(93)90056-b. PMID: 18611536.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 872 entries